Patients with depression less likely to follow critical medication plan following heart procedure

France Nouvelles Nouvelles

Patients with depression less likely to follow critical medication plan following heart procedure
France Dernières Nouvelles,France Actualités
  • 📰 medical_xpress
  • ⏱ Reading Time:
  • 49 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 23%
  • Publisher: 51%

Patients with depression less likely to follow critical medication plan following heart procedure JAMA_current jamanetworkopen

Prior research has found that patients with depression have up to a three-fold increased risk of health problems or death after a heart attack than those without depression.

"It is well-appreciated that depression carries adverse cardiovascular risk. We wanted to understand better why that is the case," said Jared W. Magnani, M.D., M.Sc., UPMC cardiologist and associate professor of medicine at Pitt."We found that 10%-20% of individuals with depression were less likely to take their medicine after PCI—which is significant—because this group is at a higher risk for serious complications or dying from a heart attack.

The study examined the records of more than 124,000 patients who underwent PCI and were diagnosed with depression by a medical provider. Magnani and his team used medical claims data that incorporated prescriptions filled at pharmacies to track if patients kept up with prescriptions.adherence is a critical component of cardiovascular disease prevention—but it is complex.

Magnani suggests that providers incorporate depression screenings to develop ways to improve medication adherence and

Nous avons résumé cette actualité afin que vous puissiez la lire rapidement. Si l'actualité vous intéresse, vous pouvez lire le texte intégral ici. Lire la suite:

medical_xpress /  🏆 101. in UK

France Dernières Nouvelles, France Actualités

Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.

Maya Jama enjoys dates with US R&B singer after getting cosy at celeb hotspotMaya Jama enjoys dates with US R&B singer after getting cosy at celeb hotspotTELLY beauty Maya Jama has been enjoying cosy nights out with an R&B singer. The new Love Island host, 28, was pictured with US star Giveon twice this week — but he did his best to hide from th…
Lire la suite »

Love Island host Maya Jama 'enjoying cosy dates with R&B singer Giveon'Love Island host Maya Jama 'enjoying cosy dates with R&B singer Giveon'Maya Jama is thought to be dating someone new, in the form of US singer Giveon - who most famously collaborated on hit song Peaches with Justin Bieber, which was No.1 worldwide
Lire la suite »

Jailed pervert doctor faces losing medical licence after abusing 48 patientsJailed pervert doctor faces losing medical licence after abusing 48 patientsKrishna Singh, 72, is currently behind bars after sexually abusing 48 female patients over the course of 35 years. A date has now been set for a hearing by the Medical Practitioners Tribunal Service.
Lire la suite »

Glasgow hospital patients to be 'Home for Lunch' in new discharge initiativeGlasgow hospital patients to be 'Home for Lunch' in new discharge initiativeFamilies are being asked to make sure appropriate arrangements are in place to get their loved ones out of the hospital before 12pm as the health board launches a new 'Home for Lunch' campaign.
Lire la suite »

Three-drug combination therapy effective in patients with high-risk chronic lymphocytic leukemia, trial showsThree-drug combination therapy effective in patients with high-risk chronic lymphocytic leukemia, trial showsA three-drug combination that sent chronic lymphocytic leukemia (CLL) into deep remission in a broad group of patients in a clinical trial is highly effective in patients with high-risk forms of the disease, a new, phase 2 clinical trial led by Dana-Farber Cancer Institute investigators indicates.
Lire la suite »

Experimental cancer therapy shows success in more than 70% of patients in global clinical trialsExperimental cancer therapy shows success in more than 70% of patients in global clinical trialsA new therapy that makes the immune system kill bone marrow cancer cells was successful in as many as 73% of patients in two clinical trials, according to researchers from The Tisch Cancer Institute at the Icahn School of Medicine at Mount Sinai.
Lire la suite »



Render Time: 2025-03-09 19:30:42